Why is 250 mg of crizotinib used?
Crizotinib, market under the brand name Crizotinib 250 mg, is a tyrosine kinase inhibitor (TKI) use in the treatment of certain types of cancer. This medication is primarily indicate for the management of non-small cell lung cancer (NSCLC) with specific genetic mutations, particularly those involving the anaplastic lymphoma kinase (ALK) gene rearrangement. In this comprehensive […]
